- Home
- MLTX vs UAMY Comparison
MLTX vs UAMY Comparison
Compare MLTX & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLTX | UAMY |
|---|---|---|
| Founded | 2021 | 1968 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | MLTX | UAMY |
|---|---|---|
| Price | $19.48 | $7.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $27.50 | $9.44 |
| AVG Volume (30 Days) | 1.3M | ★ 8.3M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $39,257,708.00 |
| Revenue This Year | N/A | $219.89 |
| Revenue Next Year | N/A | $104.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 162.80 |
| 52 Week Low | $5.95 | $2.10 |
| 52 Week High | $62.75 | $19.71 |
Technical Indicators
Market Signals| Indicator | MLTX | UAMY |
|---|---|---|
| Relative Strength Index (RSI) | 52.63 | 49.87 |
| Support Level | $15.54 | $7.04 |
| Resistance Level | $21.00 | $8.27 |
| Average True Range (ATR) | 1.10 | 0.54 |
| MACD | -0.04 | 0.09 |
| Stochastic Oscillator | 36.78 | 87.28 |
Price Performance
Historical ComparisonAbout MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.